Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_assertion type Assertion NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_head.
- NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_assertion wasGeneratedBy ECO_0000203 NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_provenance.
- NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_assertion wasDerivedFrom befree-2016 NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_provenance.
- NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_assertion SIO_000772 23821771 NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_provenance.
- NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_assertion evidence source_evidence_literature NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_provenance.
- NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_assertion description "[ER+ breast tumors had increased CRH-R2 and CRH-R1(Δ12) mRNA abundance, which was associated with decreased abundance of the mRNA encoding SRp55, compared with the amounts in ER- tumors, suggesting that estrogen contributes to the pathophysiology of ER+ breast cancer by altering CRH receptor diversity and disrupting CRH-mediated signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1090963.RApVV09ietAwg-f5UXbCb3rmqMDn1bBoEgDdtxpQkGiIE130_provenance.